His scientific interests lie mostly in Tuberculosis, Immunology, Internal medicine, Mycobacterium tuberculosis and Surgery. His research integrates issues of Meta-analysis, AIDS-Related Opportunistic Infections and Drug resistance in his study of Tuberculosis. His studies deal with areas such as Tuberculin, Disease and Lung as well as Immunology.
His study in Internal medicine is interdisciplinary in nature, drawing from both Tuberculosis diagnosis and Acquired immunodeficiency syndrome. His Mycobacterium tuberculosis study combines topics in areas such as Psychological intervention, Antibiotics, Gerontology and Contact tracing. His Surgery research integrates issues from Reproductive health, Primary care, Family medicine, Breast feeding and Medical school.
His main research concerns Tuberculosis, Immunology, Internal medicine, Mycobacterium tuberculosis and Disease. He is interested in Latent tuberculosis, which is a branch of Tuberculosis. His Immunology study combines topics from a wide range of disciplines, such as Bronchoalveolar lavage, Lung and Acquired immunodeficiency syndrome.
His research ties Sputum and Internal medicine together. His work deals with themes such as Tuberculin, Drug resistance and Virology, which intersect with Mycobacterium tuberculosis. His research links Intensive care medicine with Disease.
His primary areas of investigation include Tuberculosis, Internal medicine, Intensive care medicine, Disease and Family medicine. His Tuberculosis research is multidisciplinary, relying on both Regimen, Incidence and Cohort. The study incorporates disciplines such as Epidemiology, Psychosocial, Systematic review, Standard care and Drug resistance in addition to Intensive care medicine.
His Disease study deals with Pulmonary disease intersecting with Anesthesia, Oxygen saturation, Exacerbation and Pulse oximetry. His Family medicine research includes elements of Psychological intervention, Observational study, Randomized controlled trial and Health care. Marc Lipman has included themes like Tuberculin and Relative risk in his Latent tuberculosis study.
His primary scientific interests are in Tuberculosis, Internal medicine, Coronavirus disease 2019, Mycobacterium tuberculosis and Biomarker. The study incorporates disciplines such as Odds ratio, Epidemiology and Intensive care medicine in addition to Tuberculosis. His research on Internal medicine frequently links to adjacent areas such as Isoniazid.
His studies in Coronavirus disease 2019 integrate themes in fields like 2019-20 coronavirus outbreak, Logistic regression, Prognostic models and Emergency medicine. His research investigates the link between Mycobacterium tuberculosis and topics such as Cohort that cross with problems in Relative risk and Transmission. His Tuberculosis diagnosis study combines topics from a wide range of disciplines, such as Disease management and Incidence.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
Punam Mangtani;Ibrahim Abubakar;Cono Ariti;Rebecca Beynon.
Clinical Infectious Diseases (2014)
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis
Martina Sester;Giovanni Sotgiu;Christoph Lange;Claudia Giehl.
European Respiratory Journal (2011)
Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection
R A M Breen;C J Smith;H Bettinson;S Dart.
Drug-resistant tuberculosis: time for visionary political leadership
Ibrahim Abubakar;Ibrahim Abubakar;Matteo Zignol;Dennis Falzon;Mario Raviglione.
Lancet Infectious Diseases (2013)
Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis
I Abubakar;L Pimpin;C Ariti;R Beynon.
Health Technology Assessment (2013)
Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers
Chloe I. Bloom;Christine M. Graham;Matthew P. R. Berry;Matthew P. R. Berry;Fotini Rozakeas.
PLOS ONE (2013)
Outcome of HIV-Associated Tuberculosis in the Era of Highly Active Antiretroviral Therapy
Keertan Dheda;Fiona C. Lampe;Margaret A. Johnson;Marc C. Lipman.
The Journal of Infectious Diseases (2004)
'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19.
Swapna Mandal;Joseph Barnett;Simon E Brill;Jeremy S Brown.
Immune Reconstitution and “Unmasking” of Tuberculosis during Antiretroviral Therapy
Stephen D. Lawn;Robert J. Wilkinson;Marc C. I. Lipman;Robin Wood.
American Journal of Respiratory and Critical Care Medicine (2008)
MMP-1 drives immunopathology in human tuberculosis and transgenic mice
Paul Elkington;Takayuki Shiomi;Ronan Breen;Robert K. Nuttall.
Journal of Clinical Investigation (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: